Showing results (91-100 of 223) with videos related to
Sort By:
Pageof 23
Elife|February 16, 2017
One reporter for in-cell activity profiling of majority of protein kinase oncogenesIva Gudernova, Silvie Foldynova-Trantirkova, Barbora El Ghannamova, et al.Cancer Medicine|September 13, 2024
Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life dataPetra Belohlavkova, Daniela Zackova, Hana Klamova, et al.Leukemia & Lymphoma|June 14, 2011
Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too lateGrzegorz W Basak, Gabor Mikala, Zdenek Koristek, et al.Leukemia & Lymphoma|July 1, 2016
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemiaNadine Kutsch, Raymonde Busch, Jasmin Bahlo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemiaMartin Trbusek, Jana Smardova, Jitka Malcikova, et al.Annals of Hematology|May 9, 2019
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patientsAndrea Janikova, Renata Chloupkova, Vit Campr, et al.Haematologica|February 11, 2017
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP <i>versus</i> R-CHOP in the phase 3 LYM-3002 studyGregor Verhoef, Tadeusz Robak, Huiqiang Huang, et al.Leukemia & Lymphoma|October 6, 2020
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practiceDaniela Zackova, Hana Klamova, Petra Belohlavkova, et al.Leukemia & Lymphoma|August 22, 2015
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) databaseAndrea Janikova, Zbynek Bortlicek, Vit Campr, et al.Clinical Lymphoma & Myeloma|December 3, 2009
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapseMarta Krejci, Vlastimil Scudla, Elen Tothova, et al.Pageof 23